Skin Diseases, Papulosquamous  >>  Eucrisa (crisaborole)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Eucrisa (crisaborole) / Pfizer
NCT00762658: A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test

Completed
1
12
Europe
AN2728 Ointment, 5%, AN2728 Ointment, 2%, AN2728 Ointment, 0.5%, AN2728 Ointment Vehicle, Betnesol®-V Creme, 0.1%, betamethasone 0.1%, Protopic® Ointment, 0.1 %, tacrolimus 0.1 %
Pfizer
Psoriasis
12/07
12/07
NCT00763204: A Phase I Study to Assess Novel Cream in a Psoriasis Plaque Test

Completed
1
12
Europe
AN2728 Cream, 2%, AN2728 Cream, 1%, AN2728 Cream, 0.3%, AN2728 Cream Vehicle, Betnesol®-V Creme, 0.1%, betamethasone 0.1%
Pfizer
Psoriasis
03/08
03/08
AN2728-PSR-104, NCT01258088: Safety Study of Ointment for the Treatment of Plaque-type Psoriasis

Completed
1
16
RoW
AN2728 Ointment, AN2728 Vehicle
Pfizer
Plaque-type Psoriasis
12/10
12/10

Download Options